ID

13595

Beschreibung

Shorter Radiation Schedule for the Treatment of Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00201916

Link

https://clinicaltrials.gov/show/NCT00201916

Stichworte

  1. 18.02.16 18.02.16 -
Hochgeladen am

18. Februar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT00201916

Eligibility Prostate Cancer NCT00201916

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologic diagnosis of adenocarcinoma of the prostate with no evidence of metastatic disease to the nodes, bone or lung
Beschreibung

prostate carcinoma, no metastases

Datentyp

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2]
C0027627
stage t1a moderately or poorly differentiated, t1b, t1c or t2 by the current uicc-tnm classification
Beschreibung

tumor stage

Datentyp

boolean

Alias
UMLS CUI [1]
C1300072
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
psa > 40 mcg/l
Beschreibung

psa

Datentyp

boolean

Alias
UMLS CUI [1]
C0138741
previous therapy for carcinoma of the prostate other than biopsy or turp, including patients previously on hormone therapy for treatment of their prostate cancer
Beschreibung

previous treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
UMLS CUI [2]
C0600139
prior or active malignancy other than non-melanoma skin cancer; or colon or thyroid cancer treated a minimum of five years prior to study entry and presumed cured
Beschreibung

malignancies

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
simulated volume exceeds 1000 cm3
Beschreibung

tumor volume

Datentyp

boolean

Alias
UMLS CUI [1]
C0475276
previous pelvic radiotherapy
Beschreibung

previous pelvic radiotherapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0030797
inflammatory bowel disease
Beschreibung

inflammatory bowel disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0021390
serious non-malignant disease which would preclude radiotherapy or surgical biopsy
Beschreibung

comorbidity precluding radiotherapy or surgical biopsy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
geographic inaccessibility for follow-up
Beschreibung

geographic inaccessibility for follow-up

Datentyp

boolean

Alias
UMLS CUI [1]
C1321605
psychiatric or addictive disorder which would preclude obtaining informed consent or adherence to protocol
Beschreibung

psychiatric or addictive disorder precluding consent or compliance

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
unable to commence radiation therapy within 26 weeks of the date of last prostatic biopsy
Beschreibung

unable to commence radiation therapy within 26 weeks

Datentyp

boolean

Alias
UMLS CUI [1]
C1321605
failure to give informed consent to participate in the study
Beschreibung

failure to give informed consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0439801

Ähnliche Modelle

Eligibility Prostate Cancer NCT00201916

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
prostate carcinoma, no metastases
Item
histologic diagnosis of adenocarcinoma of the prostate with no evidence of metastatic disease to the nodes, bone or lung
boolean
C0600139 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
tumor stage
Item
stage t1a moderately or poorly differentiated, t1b, t1c or t2 by the current uicc-tnm classification
boolean
C1300072 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
psa
Item
psa > 40 mcg/l
boolean
C0138741 (UMLS CUI [1])
previous treatment
Item
previous therapy for carcinoma of the prostate other than biopsy or turp, including patients previously on hormone therapy for treatment of their prostate cancer
boolean
C0087111 (UMLS CUI [1])
C0600139 (UMLS CUI [2])
malignancies
Item
prior or active malignancy other than non-melanoma skin cancer; or colon or thyroid cancer treated a minimum of five years prior to study entry and presumed cured
boolean
C0006826 (UMLS CUI [1])
tumor volume
Item
simulated volume exceeds 1000 cm3
boolean
C0475276 (UMLS CUI [1])
previous pelvic radiotherapy
Item
previous pelvic radiotherapy
boolean
C1522449 (UMLS CUI [1,1])
C0030797 (UMLS CUI [1,2])
inflammatory bowel disease
Item
inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])
comorbidity precluding radiotherapy or surgical biopsy
Item
serious non-malignant disease which would preclude radiotherapy or surgical biopsy
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
geographic inaccessibility for follow-up
Item
geographic inaccessibility for follow-up
boolean
C1321605 (UMLS CUI [1])
psychiatric or addictive disorder precluding consent or compliance
Item
psychiatric or addictive disorder which would preclude obtaining informed consent or adherence to protocol
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
unable to commence radiation therapy within 26 weeks
Item
unable to commence radiation therapy within 26 weeks of the date of last prostatic biopsy
boolean
C1321605 (UMLS CUI [1])
failure to give informed consent
Item
failure to give informed consent to participate in the study
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video